Executive Change: Sarepta Therapeutics Inc. (NASDAQ:SRPT) Appoints Michael Severino M.D. as Chief Executive Officer
Cambridge, MA – Sarepta Therapeutics has announced the appointment of Michael Severino as Chief Executive Officer. About Sarepta Therapeutics: Sarepta Therapeutics is a global biotechnology company focused on developing precision genetic medicines for rare diseases…
